A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- Status
- RECRUITING
- Phase
- PHASE3
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Expanded Access Program for AM0010 (Pegilodecakin)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
High Dose IL 2 and Entinostat in RCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion
- Status
- COMPLETED
- Phase
- PHASE2
Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Study of BCD-135 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A